Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 22 February 2024
      Blogs
 
  21 February 2024 EU HTA Implementation: Challenges, Commitments and Collective Actions

There is less than one year to go before EU HTA is either a meaningful contributor to faster access for patients, and...

Read more →
 
 
 
      Have you missed our latest event? Watch the event recording!

This virtual event highlighted the importance of having national cardiovascular plans that include secondary prevention measures. It discussed insights from recent findings from a LSE study, offering an invaluable opportunity to understand the practical applications of this new report.

Featured speakers:

  • Haseeb Ahmad, President Europe, Novartis
  • Panos Kanavos, Associate Professor of International Health Policy at LSE
  • Emma Print, Patient Ambassador, Community Engagement Manager, FH Europe Foundation
  • Tomislav Sokol, Member of the European Parliament, EPP Group, Croatia

 

 
 
 
      Events
 
 
29 FEB 2024
  International Congress on Rare Diseases and Orphan Drugs Athens and online

Navigating the Uncharted: Advancements, Collaborations, and Hope in Rare Diseases

Learn more →
 
 
 
06 MAR 2024
  REMEDi4ALL International Drug Repurposing Conference Barcelona

Bridging boundaries: Innovating, connecting & reshaping drug repurposing

Learn more →
 
 
 
07 MAR 2024
  Digitally-enabled healthcare: Is our ecosystem on track? Brussels and online

Organised by the EU Health Coalition.

Learn more →
 
 
 
16 APR 2024
  Rare Diseases Forum: Securing Europe’s competitiveness in R&D for people living with... Brussels

Join to address how and why innovation in tackling rare diseases can support the EU’s competitiveness agenda.

Learn more →
 
 
      What we are reading
Cancer care inequalities rage across the EU, says Swedish Institute 20 February 2024  (Euractiv) Read more →
The Antwerp Declaration for a European Industrial Deal 20 February 2024  (antwerp-declaration.eu) Read more →
Cancer Screening: from Patients and Clinicians the request for a tougher action to expand the... 16 February 2024  (all-can.org) Read more →
The EU Cross-border Clinical Trials Multi-Stakeholders Initiative 15 February 2024  (jotform.com) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
▶ in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe